Details of the Drug Reposition

General Information of This Drug (ID: DMZABYH)

Drug Name
GEN3013   DMZABYH
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 1/2 [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1/2 [1]
Mantle cell lymphoma DISFREOV 2A85.5 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03625037) GEN3013 Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma. U.S. National Institutes of Health.